Markers of Differential Response to Inhaled Corticosteroid Treatment Among Children with Mild Persistent Asthma  Joe K. Gerald, MD, PhD, Lynn B. Gerald,

Slides:



Advertisements
Similar presentations
Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations  Stephen J. Teach, MD, MPH, Michelle.
Advertisements

Individualized therapy for persistent asthma in young children
Complementary and Alternative Medicine Use among Allergy Practices: Results of a Nationwide Survey of Allergists  Michael H. Land, MD, Julie Wang, MD 
The Relationship Between a Specific IgE Level and Asthma Outcomes: Results from the National Health and Nutrition Examination Survey  Whitney.
Volume 119, Issue 4, Pages (April 2001)
Advances in Diagnosing Peanut Allergy
Jonathan Malka, MD, David T
Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: Role of predictors in the setting of high adherence  Rebecca S. Gruchalla,
Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research.
Theresa W. Guilbert, MD, David T. Mauger, PhD, David B
Stephen P. Peters, MD, PhD, Eugene R. Bleecker, MD, Susan J
The Natural History of Food Allergy
Individualized therapy for persistent asthma in young children
Vitamin D Insufficiency and Asthma in a US Nationwide Study
Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial  Christine A. Sorkness,
Chronic rhinosinusitis: Potential new use for topical sulfasalazine
Complementary and Alternative Medicine in Allergy-Immunology: More Information is Needed  Leonard Bielory, MD  The Journal of Allergy and Clinical Immunology:
Dennis K. Ledford, MD, Sally Wenzel, MD 
Caregivers report a wide variety of early signs and symptoms of impending asthma exacerbations that are not different between preschool and school-aged.
Reassessment of Omalizumab-Dosing Strategies and Pharmacodynamics in Inner-City Children and Adolescents  Christine A. Sorkness, PharmD, Jeremy J. Wildfire,
Desensitization to Chemotherapeutic Agents
Intramuscular Versus Intravenous Immunoglobulin Replacement Therapy and Measurement of Immunoglobulin Levels During Immunoglobulin Replacement Therapy 
Joe K. Gerald, MD, PhD, Roni Grad, MD, William C. Bailey, MD, Lynn B
An Infant with Atopic Dermatitis and Itching After Ingestion of Milk
Childhood Asthma-Predictive Phenotype
Robert G. Hamilton, PhD, John Oppenheimer, MD 
Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children  Robert C. Strunk, MD, Stanley J. Szefler,
Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations  Stephen J. Teach, MD, MPH, Michelle.
Test for Respiratory and Asthma Control in Kids (TRACK): A caregiver-completed questionnaire for preschool-aged children  Kevin R. Murphy, MD, Robert.
Safety of Fluticasone Propionate Prescribed for Asthma During Pregnancy: A UK Population-Based Cohort Study  Rachel A. Charlton, PhD, Julia M. Snowball,
The Childhood Asthma Control Test∗: Retrospective determination and clinical validation of a cut point to identify children with very poorly controlled.
Biologic Mechanisms of Environmental Tobacco Smoke in Children with Poorly Controlled Asthma: Results from a Multicenter Clinical Trial  Jason E. Lang,
Validation of the Pregnancy Asthma Control Test
The Relationship Between a Specific IgE Level and Asthma Outcomes: Results from the National Health and Nutrition Examination Survey  Whitney.
Advances in Diagnosing Peanut Allergy
Nonadherence to Asthma Treatment: Getting Unstuck
Peter M. Wolfgram, MD, David B. Allen, MD 
Theresa W. Guilbert, MD, David T. Mauger, PhD, David B
Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing  Leonard.
Consistently very poorly controlled asthma is associated with greater activity and school impairment in children with severe or difficult-to-treat asthma 
The HEDIS Medication Management for People with Asthma Measure is Not Related to Improved Asthma Outcomes  Angelina Crans Yoon, MD, William Crawford,
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Aimee L. Speck, MD, Michael Hess, MSI, Alan P. Baptist, MD, MPH 
Management of Difficult-to-Treat Atopic Dermatitis
Penicillin Skin Testing Is a Safe and Effective Tool for Evaluating Penicillin Allergy in the Pediatric Population  Stephanie J. Fox, MD, Miguel A. Park,
Change in Asthma Control Over Time: Predictors and Outcomes
Phillip Lieberman, MD, Michael Tankersley, MD 
The Management of Eosinophilic Esophagitis
Phillip Lieberman, MD, David Golden, MD 
Do oral corticosteroids reduce the severity of acute lower respiratory tract illnesses in preschool children with recurrent wheezing?  Avraham Beigelman,
Michael Schatz, MD, MS, Robert S
Sinonasal Papillomas and Natural Killer–Cell Deficiency
A cluster-randomized trial shows telephone peer coaching for parents reduces children's asthma morbidity  Jane M. Garbutt, MB, ChB, Yan Yan, MD, PhD,
Sharon Seth, MD, David A. Khan, MD 
Cephalosporin Side Chain Cross-reactivity
Aaron Deykin, MD, Stephen C. Lazarus, MD, John V
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Development and cross-sectional validation of the Childhood Asthma Control Test  Andrew H. Liu, MD, Robert Zeiger, MD, Christine Sorkness, PharmD, Todd.
Diagnosis and management of early asthma in preschool-aged children
Reply The Journal of Allergy and Clinical Immunology: In Practice
Stanley J. Szefler, MD, Richard J
Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: Role of predictors in the setting of high adherence  Rebecca S. Gruchalla,
Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma  Anne E. Dixon, MA, BM BCh,
Azithromycin or montelukast as inhaled corticosteroid–sparing agents in moderate-to- severe childhood asthma study  Robert C. Strunk, MD, Leonard B. Bacharier,
Budesonide Inhalation Suspension Versus Montelukast in Children Aged 2 to 4 Years with Mild Persistent Asthma  Stanley J. Szefler, MD, Lars-Goran Carlsson,
Pedro Giavina-Bianchi, MD, PhD, Shih-Wen Huang, MD 
Theresa W. Guilbert, MD, David T. Mauger, PhD, David B
Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists  Michael Schatz, MD, MS, Christine.
Natural history of cow’s milk allergy
Stanley J. Szefler, MD, Brenda R. Phillips, MS, Fernando D
Presentation transcript:

Markers of Differential Response to Inhaled Corticosteroid Treatment Among Children with Mild Persistent Asthma  Joe K. Gerald, MD, PhD, Lynn B. Gerald, PhD, MSPH, Monica M. Vasquez, MPH, MEd, Wayne J. Morgan, MD, Susan J. Boehmer, MA, Robert F. Lemanske, MD, David T. Mauger, PhD, Robert C. Strunk, MD, Stanley J. Szefler, MD, Robert S. Zeiger, MD, Leonard B. Bacharier, MD, Elizabeth Bade, MD, Ronina A. Covar, MD, Theresa W. Guilbert, MD, Hengameh Heidarian-Raissy, PharmD, H. William Kelly, PharmD, Jonathan Malka-Rais, MD, Christine A. Sorkness, PharmD, Lynn M. Taussig, MD, Vernon M. Chinchilli, PhD, Fernando D. Martinez, MD  The Journal of Allergy and Clinical Immunology: In Practice  Volume 3, Issue 4, Pages 540-546.e3 (July 2015) DOI: 10.1016/j.jaip.2015.01.023 Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Figure 1 HR of TFE among participants treated with a daily inhaled corticosteroid as compared with placebo stratified by skin test result status. The Journal of Allergy and Clinical Immunology: In Practice 2015 3, 540-546.e3DOI: (10.1016/j.jaip.2015.01.023) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Figure 2 Mean change in ACDs among participants treated with a daily inhaled corticosteroid as compared with placebo stratified by sex, skin test result status, IgE level, and run-in asthma control. The Journal of Allergy and Clinical Immunology: In Practice 2015 3, 540-546.e3DOI: (10.1016/j.jaip.2015.01.023) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions